TREATMENT OF PARKINSONS-DISEASE WITH AGENTS OTHER THAN LEVODOPA AND DOPAMINE AGONISTS - CONTROVERSIES AND NEW APPROACHES

被引：34
作者：
LANG, AE
机构：
来源：
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 1984年 / 11卷 / 01期
关键词：
D O I：
10.1017/S0317167100046436
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：210 / 220
页数：11
相关论文
共 146 条
[11]   NOMIFENSINE IN PARKINSONS-DISEASE [J].
BEDARD, P ;
PARKES, JD ;
MARSDEN, CD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 :S187-S190
[12]   EFFECT OF NEW DOPAMINE-BLOCKING AGENT (OXIPEROMIDE) ON DRUG-INDUCED DYSKINESIAS IN PARKINSONS-DISEASE AND SPONTANEOUS DYSKINESIAS [J].
BEDARD, P ;
PARKES, JD ;
MARSDEN, CD .
BRITISH MEDICAL JOURNAL, 1978, 1 (6118) :954-956
[13]  
BIRKMAYE.W, 1972, NERVENARZT, V43, P76
[14]   POTENTIATION OF ANTI AKINETIC EFFECT AFTER L-DOPA TREATMENT BY AN INHIBITOR OF MAO-B, DEPRENIL [J].
BIRKMAYER, W ;
RIEDERER, P ;
YOUDIM, MBH ;
LINAUER, W .
JOURNAL OF NEURAL TRANSMISSION, 1975, 36 (3-4) :303-326
[15]  
BIRKMAYER W, 1962, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V203, P560, DOI 10.1007/BF00343235
[16]   (-)DEPRENYL IN THE TREATMENT OF PARKINSONS-DISEASE [J].
BIRKMAYER, W ;
RIEDERER, P ;
YOUDIM, MBH .
CLINICAL NEUROPHARMACOLOGY, 1982, 5 (02) :195-230
[17]  
BIRKMAYER W, 1977, LANCET, V1, P439
[18]   ENDORPHINS - PROFOUND BEHAVIORAL-EFFECTS IN RATS SUGGEST NEW ETIOLOGICAL FACTORS IN MENTAL-ILLNESS [J].
BLOOM, F ;
SEGAL, D ;
LING, N ;
GUILLEMIN, R .
SCIENCE, 1976, 194 (4265) :630-632
[19]   (-) BACLOFEN DECREASES NEUROTRANSMITTER RELEASE IN THE MAMMALIAN CNS BY AN ACTION AT A NOVEL GABA RECEPTOR [J].
BOWERY, NG ;
HILL, DR ;
HUDSON, AL ;
DOBLE, A ;
MIDDLEMISS, DN ;
SHAW, J ;
TURNBULL, M .
NATURE, 1980, 283 (5742) :92-94
[20]  
BROLL M, 1977, J PHARMACOL-PARIS, V8, P524
12345678910